Page last updated: 2024-08-24

plerixafor and pemetrexed

plerixafor has been researched along with pemetrexed in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Hou, S; Kadoch, O; Li, H; Li, J; Li, S; Li, T; Lin, Q; Xie, L; Xu, Z; Yang, YL1

Reviews

1 review(s) available for plerixafor and pemetrexed

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for plerixafor and pemetrexed

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2019, Volume: 67, Issue:2

    Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction

2019